X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (87) 87
humans (83) 83
index medicus (76) 76
transplantation (68) 68
adult (57) 57
female (57) 57
male (55) 55
middle aged (54) 54
hematology, oncology and palliative medicine (52) 52
aged (40) 40
article (36) 36
hematopoietic stem cells (34) 34
adolescent (33) 33
oncology (31) 31
leukemia (29) 29
cancer (28) 28
stem cells (28) 28
young adult (25) 25
analysis (22) 22
chemotherapy (22) 22
hemic and lymphatic diseases (21) 21
care and treatment (20) 20
stem-cell transplantation (20) 20
survival (20) 20
immunology (19) 19
research (18) 18
treatment outcome (18) 18
hematopoietic stem cell transplantation (17) 17
prognosis (17) 17
retrospective studies (17) 17
bone marrow (16) 16
disease-free survival (16) 16
transplantation, homologous (16) 16
acute myeloid leukemia (15) 15
hematopoietic stem cell transplantation - methods (15) 15
therapy (15) 15
bone-marrow-transplantation (14) 14
health aspects (14) 14
acute disease (13) 13
survival rate (13) 13
abridged index medicus (12) 12
survival analysis (12) 12
acute lymphoblastic-leukemia (11) 11
acute lymphocytic leukemia (11) 11
acute myelogenous leukemia (11) 11
acute myeloid-leukemia (11) 11
aged, 80 and over (11) 11
antineoplastic agents - therapeutic use (11) 11
cytogenetics (11) 11
patient outcomes (11) 11
precursor cell lymphoblastic leukemia-lymphoma - therapy (11) 11
acute lymphoblastic leukemia (10) 10
diagnosis (10) 10
mortality (10) 10
recurrence (10) 10
risk factors (10) 10
transplantation conditioning (10) 10
adults (9) 9
aml (9) 9
clinical trials (9) 9
hematopoietic stem cell transplantation - adverse effects (9) 9
kaplan-meier estimate (9) 9
leukemia, myeloid, acute - drug therapy (9) 9
minimal residual disease (9) 9
acute lymphocytic-leukemia (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
child (8) 8
cytarabine (8) 8
leukemia, myeloid, acute - genetics (8) 8
leukemia, myeloid, acute - mortality (8) 8
mutation (8) 8
myelodysplastic syndrome (8) 8
oncology, experimental (8) 8
relapse (8) 8
transplantation, autologous (8) 8
age factors (7) 7
animals (7) 7
bone marrow transplantation (7) 7
child, preschool (7) 7
graft vs host disease - etiology (7) 7
hematopoietic-cell transplantation (7) 7
immunotherapy (7) 7
infant (7) 7
medical colleges (7) 7
medicine, general & internal (7) 7
philadelphia chromosome (7) 7
randomized-trial (7) 7
risk (7) 7
surgical procedures, operative (7) 7
versus-host-disease (7) 7
allogeneic (6) 6
allogeneic transplantation (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
bone-marrow (6) 6
bone-marrow transplantation (6) 6
combined modality therapy (6) 6
cyclophosphamide (6) 6
hyper-cvad (6) 6
medical research (6) 6
patients (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 795 - 795
Abstract This study was coordinated by the ECOG-ACRIN Cancer Research Group (Robert L. Comis, MD and Mitchell D. Schnall, MD, PhD, Group Co-Chairs) and the... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 1752 - 1752
Abstract Abstract 1752 Background: Patients with primary (PMF) or post-polycythemia vera/essential thrombocythemia (post-PV/ET MF) myelofibrosis often harbor a... 
Journal Article
Fisheries Oceanography, ISSN 1054-6006, 03/2008, Volume 17, Issue 2, pp. 137 - 146
Pacific capelin (Mallotus villosus) populations declined dramatically in the Northeastern Pacific following ocean warming after the regime shift of 1977, but... 
Glacier Bay | spawning habitat | maturity | Mallotus villosus | marine climate | oceanography | Marine climate | Spawning habitat | Oceanography | Maturity | FJORD | TIDEWATER GLACIERS | GULF | PATTERNS | FISHERIES | COMMUNITY | HYPOTHESIS | FISH | ECOSYSTEM | LIONS EUMETOPIAS-JUBATUS | CLIMATE | Analysis | Glaciers
Journal Article
Journal of Animal Ecology, ISSN 0021-8790, 11/2004, Volume 73, Issue 6, pp. 1149 - 1156
1. The quality-variability trade-off hypothesis predicts that (i) energy density (kJ g ) and spatial-temporal variability in abundance are positively... 
foraging | resource quality | resource heterogeneity | patchiness | risk sensitivity | Resource heterogeneity | Risk sensitivity | Patchiness | Resource quality | Foraging | CEPPHUS-COLUMBA | FORAGE FISHES | STRATEGIES | DISTRIBUTIONS | ZOOLOGY | COMPETITION | ECOLOGY | SOCIAL-ORGANIZATION | INVERTEBRATES | SEABIRD | FOOD
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2017, Volume 23, Issue 4, pp. 899 - 907
Purpose: The PARP inhibitor veliparib delays DNA repair and potentiates cytotoxicity of multiple classes of chemotherapy drugs, including topoisomerase I... 
TRANSFORMATION | CELLS | REPAIR | ONCOLOGY | RECOMMENDATIONS | BONE-MARROW | ABT-888 | MUTATION | ACUTE MYELOID-LEUKEMIA | CANCER | POLY(ADP-RIBOSE) POLYMERASE INHIBITOR | Fanconi Anemia Complementation Group D2 Protein - genetics | Humans | Leukemia, Myelomonocytic, Chronic - genetics | Middle Aged | Male | Carboplatin - pharmacokinetics | Leukemia, Myelomonocytic, Chronic - drug therapy | Drug-Related Side Effects and Adverse Reactions - pathology | Carboplatin - adverse effects | Dose-Response Relationship, Drug | Benzimidazoles - administration & dosage | Adult | Female | Leukemia, Myelomonocytic, Chronic - pathology | Benzimidazoles - adverse effects | Leukemia, Biphenotypic, Acute - drug therapy | Benzimidazoles - pharmacokinetics | Carboplatin - administration & dosage | Topotecan - adverse effects | Myeloproliferative Disorders - drug therapy | Poly (ADP-Ribose) Polymerase-1 - antagonists & inhibitors | Disease-Free Survival | Topotecan - pharmacokinetics | Topotecan - administration & dosage | Aged | Poly (ADP-Ribose) Polymerase-1 - genetics | Drugs | Phosphorylation | Histone H2A | Toxicity | Leukemia | DNA damage | Cytotoxicity | Dosage | DNA repair | Neoplasms | Confidence intervals | Infusion | Ubiquitination | Chronic myelomonocytic leukemia | Repair | Deoxyribonucleic acid--DNA | CD34 antigen | Myelomonocytic leukemia | Mucositis | DNA topoisomerase | Poly(ADP-ribose) polymerase | Topotecan | Patients | Chemotherapy | Inhibitors | Experimental design | Carboplatin | Auditory defects | Cancer | Tumors
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2012, Volume 366, Issue 12, pp. 1079 - 1089
Journal Article
Clinical Lymphoma Myeloma and Leukemia, ISSN 2152-2650, 09/2017, Volume 17, pp. S13 - S14
Journal Article
Blood and lymphatic cancer : targets and therapy, ISSN 1179-9889, 2018, Volume 8, pp. 47 - 61
Journal Article
Drugs, ISSN 0012-6667, 3/2011, Volume 71, Issue 4, pp. 415 - 442
Acute lymphoblastic leukaemia (ALL) in adults is a challenging malignancy in that many patients will show evidence of initial chemotherapy responsiveness but... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Nilotinib | Research-and-development | Moxetumomab-pasudotox | Sirolimus | Decitabine | Temsirolimus | Acute-lymphoblastic-leukaemia | Nelarabine | CAT-3888 | Cytarabine | Blinatumomab | Inotuzumab-ozogamicin | Methotrexate | Everolimus | Alvocidib | Epratuzumab | Dasatinib | Imatinib | Bortezomib | Talotrexin | Etoposide | Rituximab | Clofarabine | Alemtuzumab | Vincristine | Forodesine | Cyclophosphamide | Fludarabine | Cladribine | Asparaginase | MK-0752 | ACUTE LYMPHOCYTIC-LEUKEMIA | HIGH-DOSE METHOTREXATE | PROTEASOME INHIBITOR BORTEZOMIB | PHARMACOLOGY & PHARMACY | INTRATHECAL LIPOSOMAL CYTARABINE | TOXICOLOGY | STEM-CELL TRANSPLANTATION | CHROMOSOME-POSITIVE LEUKEMIA | MINIMAL RESIDUAL DISEASE | 1ST COMPLETE REMISSION | CHILDRENS ONCOLOGY GROUP | CHRONIC MYELOID-LEUKEMIA | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Animals | Age Factors | Precursor Cell Lymphoblastic Leukemia-Lymphoma - surgery | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Bone Marrow Transplantation | Combined Modality Therapy | Antimitotic agents | Complications and side effects | Chemotherapy | Dosage and administration | Acute lymphocytic leukemia | Diagnosis | Research | Drug therapy | Antineoplastic agents | Health aspects | Methods | Cancer
Journal Article
American Journal of Hematology, ISSN 0361-8609, 08/2018, Volume 93, Issue 8, pp. 1074 - 1081
This study examines the long‐term OS of relapsed AML patients who were enrolled to 9 successive ECOG‐ACRIN trials for newly diagnosed AML, during 1984‐2008.... 
ADULT PATIENTS | POSTREMISSION THERAPY | COLONY-STIMULATING FACTOR | PROGNOSTIC-FACTORS | ACUTE MYELOGENOUS LEUKEMIA | 1ST REMISSION | CELL TRANSPLANTATION | SALVAGE THERAPY | ACUTE MYELOID-LEUKEMIA | HEMATOLOGY | COOPERATIVE-ONCOLOGY-GROUP | Relapse | Oncology, Experimental | Analysis | Social service | Patient outcomes | Cytogenetics | Research | Cancer | Diseases
Journal Article
Cancer, ISSN 0008-543X, 07/2015, Volume 121, Issue 14, pp. 2303 - 2313
The widespread use of complementary and alternative medicine (CAM) in cancer survivors is well known despite a paucity of scientific evidence to support its... 
hematopoietic stem cell transplant (HCT) | quality of life | survivors | complementary and alternative medicine (CAM) | MANAGEMENT | ORAL EICOSAPENTAENOIC ACID | RANDOMIZED CONTROLLED-TRIAL | ALTERNATIVE MEDICINE | MULTIMODAL INTERVENTION | ONCOLOGY | CANCER-TREATMENT | MUSIC-THERAPY | CLINICAL-TRIALS | QUALITY-OF-LIFE | RELAXATION BREATHING EXERCISE | Therapeutic Touch - utilization | Stress, Psychological - prevention & control | Uncertainty | Meditation | Humans | Mind-Body Therapies - utilization | Exercise Movement Techniques - utilization | Acupuncture Therapy - utilization | Qigong - utilization | Materia Medica - therapeutic use | Manipulation, Spinal - utilization | Minerals - therapeutic use | Aromatherapy - utilization | Stress, Psychological - therapy | Relaxation Therapy - utilization | Survivors | Vitamins - therapeutic use | Randomized Controlled Trials as Topic | Tai Ji - utilization | Complementary Therapies - utilization | Music Therapy | Massage - utilization | Probiotics - therapeutic use | Hematopoietic Stem Cell Transplantation - psychology | Hypnosis | Yoga | Plants, Medicinal | Stress, Psychological - etiology | Cancer survivors | Usage | Alternative medicine | Analysis | Transplantation | Health aspects | Hematopoietic stem cells | Quality of life | Therapy | Transplants & implants | Clinical trials | Systematic review | Patients | Survival | Hemopoiesis | Literature reviews | Cost-benefit analysis | Medicine | Randomization | Stem cells | Cancer
Journal Article
Cancer Cell, ISSN 1535-6108, 02/2016, Volume 29, Issue 2, pp. 186 - 200
Journal Article
Journal Article